Omega Healthcare Investors (OHI) financial statements
Omega Healthcare Investors reported revenue of $1.2B in fiscal 2025, up 3.1% a year over 9 years.
Net income was $590M.
Free cash flow was $798M, and the company returned $780M in dividends.
The diluted share count rose 51% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Omega Healthcare Investors's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $901M | $908M | $882M | $929M | $892M | $1.1B | $878M | $950M | $1.1B | $1.2B |
| Selling, general and admin | $46M | $48M | $64M | $58M | $60M | $65M | $69M | $82M | $88M | $104M |
| Operating income | $560M | $315M | $498M | $552M | — | — | — | — | — | — |
| Interest expense | $164M | $189M | $192M | $209M | $223M | $235M | $233M | $236M | $222M | $215M |
| Pre-tax income | $384M | $106M | $297M | $344M | $162M | $416M | $436M | $256M | $421M | $624M |
| Income tax | $1M | $3M | $3M | $3M | $5M | $4M | $5M | $6M | $11M | $15M |
| Net income | $366M | $100M | $282M | $341M | $159M | $417M | $427M | $242M | $406M | $590M |
| EPS (diluted) | $1.90 | $0.51 | $1.40 | $1.58 | $0.70 | $1.75 | $1.80 | $1.00 | $1.55 | $1.94 |
| Diluted shares | 202M | 207M | 210M | 222M | 235M | 244M | 244M | 250M | 270M | 305M |
| Operating margin | 62.2% | 34.7% | 56.4% | 59.4% | — | — | — | — | — | — |
| Net margin | 40.7% | 11.1% | 31.9% | 36.7% | 17.9% | 39.2% | 48.6% | 25.5% | 38.6% | 49.6% |
Balance sheet
Fiscal years, from Omega Healthcare Investors's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $94M | $86M | $10M | $24M | $164M | $21M | $297M | $443M | $518M | $27M |
| Goodwill | $643M | $645M | $644M | $644M | $652M | $651M | $643M | $644M | $644M | $645M |
| Total assets | $8.9B | $8.8B | $8.6B | $9.8B | $9.5B | $9.6B | $9.4B | $9.1B | $9.9B | $10.0B |
| Total liabilities | $4.7B | $4.9B | $4.8B | $5.5B | $5.5B | $5.5B | $5.6B | $5.4B | $5.2B | $4.6B |
| Shareholders' equity | $3.9B | $3.6B | $3.4B | $4.1B | $3.8B | $3.9B | $3.6B | $3.6B | $4.5B | $5.2B |
| Net debt | -$94M | -$86M | -$10M | -$24M | -$164M | -$21M | -$297M | -$443M | -$518M | -$27M |
Cash flow
Fiscal years, from Omega Healthcare Investors's 10-K filings with the SEC.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $625M | $578M | $499M | $554M | $708M | $722M | $626M | $618M | $749M | $879M |
| Capital spending | $40M | $38M | $30M | $53M | $31M | $45M | $47M | $38M | $38M | $81M |
| Free cash flow | $584M | $540M | $470M | $501M | $677M | $677M | $579M | $580M | $712M | $798M |
| Stock-based compensation | $14M | $15M | $16M | $15M | $19M | $21M | $27M | $35M | $37M | $44M |
| Dividends paid | $453M | $503M | $529M | $564M | $612M | $638M | $633M | $644M | $685M | $780M |
| Share buybacks (net) | — | — | — | — | — | — | -$142M | — | — | — |
| Free cash flow margin | 64.9% | 59.5% | 53.3% | 53.9% | 75.9% | 63.7% | 65.9% | 61.0% | 67.7% | 67.0% |
| Dividends per share | $2.25 | $2.43 | $2.52 | $2.54 | $2.60 | $2.61 | $2.59 | $2.57 | $2.53 | $2.56 |
Questions
What was Omega Healthcare Investors's revenue in 2025?
$1.2B in fiscal 2025, from its 10-K filing.
How much free cash flow does Omega Healthcare Investors generate?
$798M in fiscal 2025 (operating cash flow minus capital spending).
From Omega Healthcare Investors's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.